Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
18 20 Search
2025
Characteristics, outcome, and prognostic factors of young patients with central nervous system World Health Organization grade 3 oligodendrogliomas IDH‐mutant and 1p/19q codeleted: A French POLA network study
Cancer
2024
Clinicopathologic and prognostic significance of tumor-associated macrophages in cervical cancer: a systematic review and meta-analysis
Clinical and Translational Oncology
2024
The prognostic value of Th17/Treg cell in cervical cancer: a systematic review and meta-analysis
Frontiers in Oncology
2023
Infiltration by Intratumor and Stromal CD8 and CD68 in Cervical Cancer
Medicina
2023
Disfunction of communication among immune cells in minimal-deviation adenocarcinoma of the cervix as an immunotherapeutic opportunity
International Immunopharmacology
2023
Increased Early Cancer Diagnosis: Unveiling Immune-Cancer Biology to Explain Clinical “Overdiagnosis”
Cancers
2023
The construction of a prognostic model of cervical cancer based on four immune-related LncRNAs and an exploration of the correlations between the model and oxidative stress
Frontiers in Pharmacology
2023
CNN stability training improves robustness to scanner and IHC-based image variability for epithelium segmentation in cervical histology
Frontiers in Medicine
2022
Cluster of differentiation frequency on antigen presenting-cells: The next step to cervical cancer prognosis?
International Immunopharmacology
2022
The prognostic impact of the immune microenvironment in small-cell neuroendocrine carcinoma of the uterine cervix: PD-L1 and immune cell subtypes
Cancer Cell International
2022
Improved Prognosis of Treatment Failure in Cervical Cancer with Nontumor PET/CT Radiomics
Journal of Nuclear Medicine
2021
The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions—Evidence for Estrogen as an Immunomodulator
Frontiers in Cellular and Infection Microbiology
2021
Construction of Immune‐Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer
BioMed Research International
2021
The augment of regulatory T cells undermines the efficacy of anti-PD-L1 treatment in cervical cancer
BMC Immunology
2020
<p>Cervical Cancer: Emerging Immune Landscape and Treatment</p>
OncoTargets and Therapy
2020
Six-lncRNA Immune Prognostic Signature for Cervical Cancer
Frontiers in Genetics
2020
Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead toward personalized treatment
International Journal of Cancer
2020
Tackling Resistance to Cancer Immunotherapy: What Do We Know?
Molecules
Additional cited-by details will be shown when available from Crossref